Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iodine-131 Tositumomab vs Tositumomab in Relapsed/Refractory NHL
NCT01573000Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 1998
- Primary completion
- Apr 2001
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of iodine i 131 tositumomab in non-Hodgkin lymphoma (NHL), sponsored by GSK. Started Sep 1998; status: completed.
02
Drugs
iodine i 131 tositumomab
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01573000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01573000.